[1]
I. H. Sagineedi, “PHARMACOVIGILANCE AND PATIENT SAFETY: MONITORING AND REPORTING ADVERSE DRUG REACTIONS”, J. Dru. Rec., vol. 1, no. 1, pp. 7–9, Dec. 2025.